Cargando…
Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet?
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398715/ https://www.ncbi.nlm.nih.gov/pubmed/28426761 http://dx.doi.org/10.1371/journal.pone.0176644 |
_version_ | 1783230515165265920 |
---|---|
author | Amtul, Zareen Keet, Mary Wang, Lin Merrifield, Peter Westaway, David Rozmahel, Richard F. |
author_facet | Amtul, Zareen Keet, Mary Wang, Lin Merrifield, Peter Westaway, David Rozmahel, Richard F. |
author_sort | Amtul, Zareen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5398715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53987152017-05-04 Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet? Amtul, Zareen Keet, Mary Wang, Lin Merrifield, Peter Westaway, David Rozmahel, Richard F. PLoS One Correction Public Library of Science 2017-04-20 /pmc/articles/PMC5398715/ /pubmed/28426761 http://dx.doi.org/10.1371/journal.pone.0176644 Text en © 2017 Amtul et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Correction Amtul, Zareen Keet, Mary Wang, Lin Merrifield, Peter Westaway, David Rozmahel, Richard F. Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet? |
title | Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet? |
title_full | Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet? |
title_fullStr | Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet? |
title_full_unstemmed | Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet? |
title_short | Correction: DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet? |
title_sort | correction: dha supplemented in peptamen diet offers no advantage in pathways to amyloidosis: is it time to evaluate composite lipid diet? |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398715/ https://www.ncbi.nlm.nih.gov/pubmed/28426761 http://dx.doi.org/10.1371/journal.pone.0176644 |
work_keys_str_mv | AT amtulzareen correctiondhasupplementedinpeptamendietoffersnoadvantageinpathwaystoamyloidosisisittimetoevaluatecompositelipiddiet AT keetmary correctiondhasupplementedinpeptamendietoffersnoadvantageinpathwaystoamyloidosisisittimetoevaluatecompositelipiddiet AT wanglin correctiondhasupplementedinpeptamendietoffersnoadvantageinpathwaystoamyloidosisisittimetoevaluatecompositelipiddiet AT merrifieldpeter correctiondhasupplementedinpeptamendietoffersnoadvantageinpathwaystoamyloidosisisittimetoevaluatecompositelipiddiet AT westawaydavid correctiondhasupplementedinpeptamendietoffersnoadvantageinpathwaystoamyloidosisisittimetoevaluatecompositelipiddiet AT rozmahelrichardf correctiondhasupplementedinpeptamendietoffersnoadvantageinpathwaystoamyloidosisisittimetoevaluatecompositelipiddiet |